1. United States Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
BioForce Nanosciences Holdings, Inc.

BioForce Nanosciences Holdings, Inc.

OOTC:BFNH
8.38
USD
+0.86
(+11.44%)
0.00EPS
55.36MMarket Cap
BioForce Nanosciences Holdings, Inc.
OTC:BFNH
(OTC Markets)

Recent

price

8.38

P/E

ratio

- -

div

yld

- -

ROIC.AI

2006
2007
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
0.09
0.23
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
-0.87
-0.83
- -
- -
- -
- -
- -
- -
- -
- -
-9.72
-0.02
-0.02
-0.02
-0.02
-0.04
- -
Basic EPS, GAAP
-0.66
-0.65
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.78
0.44
- -
- -
- -
- -
- -
- -
- -
- -
-0.01
-0.03
-0.05
-0.06
-0.08
-0.02
0.07
Book Value per Share
0.65
0.3
- -
- -
- -
- -
- -
- -
- -
- -
-0.01
-0.03
-0.05
-0.06
-0.08
-0.02
0.07
Tangible Book Value per Share
5
5
7
7
7
7
15
15
15
15
16
29
29
29
29
33
34
Basic Weighted Avg Shares
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
-757.99
-337.51
- -
82.96
- -
- -
-69.24
-694.69
-409.2
-261.82
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-4
-4
- -
- -
- -
- -
- -
- -
- -
- -
-158
-1
- -
- -
- -
-1
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-957.41
-342.59
- -
82.96
- -
- -
-69.24
-694.69
-415.32
-261.82
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
3
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
-2
-2
-1
2
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
4
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
-2
-2
-1
2
Total Equity
- -
- -
- -
86.37
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
86.37
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
-197.06
-129.9
-0.38
86.37
-12.1
-12.88
-52.65
-596.19
-356.46
-120.7
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
34
34
34
Market Capitalization
19
12
55

Working Capital

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
- -
- -
2
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-18.38%
36.84%
-73.13%
Free Cash Flow
- -
-1.85%
6.37%
Net Income, GAAP
34,100.81%
12.32%
163.43%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.02
2025
-0.03
- -
- -
- -
-0.04
2026
- -
0.01
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
BioForce Nanosciences Holdings, Inc. engages in the provision of natural vitamins, minerals, nutritional supplements, powders, and beverages designed to promote healthier lifestyles for active individuals across various age groups. The company offers private label nutritional products distributed through nutrition retailers, sporting goods stores, supermarkets, mass merchandisers, and online channels including its BioForce Eclipse brand retailed at www.bioforceeclipse.com. Founded in 1999 and headquartered in Virginia Beach, Virginia, BioForce Nanosciences Holdings, Inc. focuses on expanding its flagship BioForce Eclipse nutritional powder product into household markets across the United States. Recent developments include strategic efforts to broaden distribution and increase consumer penetration through retail and e-commerce platforms, alongside marketing via social media and telemarketing channels. The company's product portfolio and operational emphasis reflect its core business in health supplements targeting active lifestyle consumers with an expanding footprint in the U.S. nutrition retail sector.

Company News

Company News APIChatGPT

  • globenewswire.com

    BioForce Nanosciences Holdings, Inc. Announces Major Independently Verified Potential U.S. Oil Discovery